Decibel Therapeutics Announces Pricing of Initial Public Offering
11 févr. 2021 21h51 HE
|
Decibel Therapeutics, Inc.
BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...